share_log

JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $110

Benzinga ·  Dec 17 00:51  · Ratings

JP Morgan analyst Robbie Marcus maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $100 to $110.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment